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Abstract-Using two-stage coronary ligation-, digitalis and adrenaline-induced canine ventricular arrhythmias, antiarrhythmic effects of nicainoprol were examined in dogs, and the minimum effective plasma concentration for each arrhythmia model was determined.
Nicainoprol suppressed the arrhythmias, and the minimum effective plasma concentrations for arrhythmias induced by 48 hr coronary ligation, digitalis and adrenaline were 8.9 ag/ml (by 5 mg/kg, i.v.), 3.0 ug/ml (by 3 mg/kg, i.v.) and 2.7 ag/ml (by 3 mg/kg, i.v.), respectively. The concentration for coronary ligation arrhythmia was higher than those for the digitalis and adrenaline arrhyth mias. This pharmacological profile is similar to those of aprindine and propafenone. Nicainoprol induced some central nervous system effect including vomiting in con scious coronary ligated dogs. Though intravenous nicainoprol (5 mg/kg) was not ef fective on 24 hr coronary ligation arrhythmia, an oral dose of 30 to 40 mg/kg was ef fective. These results indicate that it may become a clinically useful antiarrhythmic drug.
Nicainoprol, 8 (3 isopropylamino 2 hy droxy-propoxy) -1 nicotinoyl -1,2,3,4 tetra hydroquinoline, is a new synthetic class 1 antiarrhythmic agent, and it was reported to have a shortening effect on the action potential duration of canine Purkinje fiber, but a lengthening effect on that of canine ventricular muscle (1) , with slight beta block ing activity (2) . Preliminary reports showed that it is effective in animal and clinical ar rhythmias (2, 3) .
We have been reporting effects of various antiarrhythmic drugs using canine ventri cular arrhythmia models (4-6) and classified antiarrhythmic drugs based on their pharma cological effectiveness (7). Using the same experimental methods, the present experi ment was designed to examine antiarrhyth mic effects of the class 1 drug nicainoprol qualitatively and quantitatively in comparison with other antiarrhythmic drugs.
Materials and Methods

Production
of two-stage  coronary  ligation  induced  arrhythmia:  Fourteen  beagle  dogs,  weighing 7-9 kg, were anesthetized initially with thiopental sodium. As reported earlier (4), the chest was opened and a two-stage coronary ligation was performed under halo thane anesthesia after intubation under in travenous thiopental sodium, 30 mg/kg. Bipolar atrial electrodes were sutured on the left atrial appendage, and polyethylene can nulae were inserted into the left jugular vein and into the left internal carotid artery for in jection of drugs and withdrawal of blood samples and for blood pressure recording, respectively.
Experiments were done without anesthesia at 24 and 48 hr after coronary ligation. The lead II ECG, atrial electrogram from the left atrial appendage, and the blood pressure were recorded continuously using telemetry sys tems (Nihon Kohden and Nishimu Electro nics Industries).
Intravenous nicainoprol, 5 mg/kg, was injected through a venous can nula over a period of 3 to 5 sec. Rapid bolus injection was used to apply the two compart ment model for analysis of the plasma con centration time curves. Venous samples were drawn from the cannula 5 min before and at 1, 3, 5, 10, 15, 30 and 60 min after injec tion of nicainoprol.
For oral administration studies, 30-40 mg/kg nicainoprol in a gelatin capsule was administered to 6 dogs 24 hr after coronary ligation. Venous samples were drawn up to 24 hr after coronary ligation.
Production of digitalis-induced arrhyth mia: Six mongrel dogs of either sex, weigh ing 8-15 kg, were anesthetized with 30 mg/ kg of pentobarbital sodium. A supplemental dose of 10 mg/kg was sometimes required. As reported earlier (5) , 40 ug/kg ouabain was injected intravenously and then fol lowed by an additional 10 ,ug/kg every 20 min until stable ventricular arrhythmia was pro duced. Nicainoprol, 3 mg/kg, was injected intravenously through a cannula in the femoral vein over a period of 3 to 5 sec.
The lead II ECG, atrial electrogram from catheter tip electrodes inserted from the right external jugular vein into the right atrium, and the blood pressure were continuously re corded through a catheter in the right femoral artery. Venous blood samples were drawn from the jugular vein 5 min before and at 1, 3, 5, 10, 15, 30 and 60 min after nicain oprol injection.
Production of adrenaline-induced arrhyth mia: Seven mongrel dogs of either sex , weighing 7-15 kg, were anesthetized in itially with thiopental sodium. As reported earlier (6), after intubation, 1.0%, halothane vaporized with 100% oxygen was adminis tered with a volume-limited ventilator . Ad renaline was infused through the left femoral vein at a rate of 2.5 ,ug/kg/min. If multifocal ventricular tachycardia was not induced , a higher infusion rate was employed. At 3 min after the start of adrenaline infusion, up to 3 mg/kg nicainoprol was injected into the right femoral vein over a period of 3 to 5 sec.
The lead II ECG, atria! electrogram from the catheter tip electrodes in the right atrium and blood pressure were continuously recorded. Venous samples were drawn from the jugular vein 1 min before and at 1, 3, 5, 10 and 15 min after injection.
Plasma nicainoprol assay: A sensitive and specific determination of nicainoprol in plasma was performed using the high per formance liquid chromatographic method (8), at the Nippon Roussel K.K., Tokyo, Japan.
Determination of the minimum effective plasma concentration:
The severity of ar rhythmia was expressed by the arrhythmic ratio: number of ventricular ectopic beats divided by the total heart rate. Ventricular beats were judged by the different shape of the ventricular complex from the normal QRS complex. For the arrhythmias used, the arrhythmic ratios before drug injection were almost 1, and there were no spontaneous im provements in these ratios. If the arrhythmic ratio after drug administration was decreased significantly from the 0 time value (P<0.05), the drug was judged as having an antiar rhythmic effect. For statistical analysis, Student's t-test for paired data were used to evaluate the difference as compared to the 0 time values. As reported earlier (4-7), the minimum effective plasma concentration of nicainoprol was determined as follows: The last minute of statistically significant decrease (P<0.05) in the arrhythmic ratio compared with that at 0 time was determined. Then the corresponding plasma concentration was calculated from the experimentally derived plasma concentration-time equations, and this was regarded as the minimum effective plasma concentration.
Results
Effects
of nicainoprol on two-stage coronary ligation induced arrhythmia: After 1-2 days of coronary ligation, beagle dogs showed ventricular tachycardia; and as shown in Fig. 1 , the values of the arrhythmic ratios were almost 1, 5 min before and just before injection (0 time). The preliminary experi ments using 1-5 mg/kg of nicainoprol, i.v., showed that at doses of 1-3 mg/kg, nicaino prol had almost no antiarrhythmic effect, and 5 mg/kg showed only a weak antiarrhythmic effect, but because of its central nervous sys tem exciting effect, such as irritability and vomiting in 3 out of 6 dogs, higher doses could not be examined in 24 hr after coronary ligation. As shown in Fig. 1 , this dose de creased only the total heart rate. As shown in Fig. 2 , arrhythmia was still present at 48 hr after coronary ligation, and the plasma con centration of nicainoprol, just before the 48 hr experiment, was zero, although 5 mg/kg had been administered 24 hr before. The same 5 mg/kg nicainoprol now showed antiarrhyth Fig. 1 The plasma concentration-time curve fitted well with that predicted by the two-compart ment open model. The parameters of the curve of the 24 hr experiment were analyzed using the non-linear regression program "MULTI" (9) and an NEC PC-9801 Vm com puter (Tokyo, Japan).
The curve was ex pressed as concentration (C`p)=Ae-a`+Be-P`, and the parameters were: A=36.86±11.42 ,ug/ml, alpha=0.95±0.11 /min, B=7.07±1.22 ,ag/ml, and beta =0.012±0.003/min (n=6).
Those for the 48 hr experiments were: A= 38.98±27.14 /ig/ml, alpha =0.74±0.1 8/min, B=11.31±0.97 i g/ml, and beta=0.010± 0.002/min (n=7). The minimum antiarrhyth mic plasma concentration for the canine 48 hr coronary ligation-induced arrhythmia was calculated to be 8.9±0.8 itg/ml (at 24 min).
The effect of oral administration of nicaino prol was examined in 7 other dogs after 24 hr coronary ligation. We observed drug effects continuously up to 6 hr after administration. After 30-40 mg/kg of nicainoprol, p.o., an tiarrhythmic effects gradually appeared, as shown in the individual graphs of Fig. 3 Effects of nicainoprol on digitalis-induced arrhythmia: After the intravenous injection of a total dose of 70-90 /cg/kg ouabain, almost all the beats were of ventricular origin, as shown in the -5 and Otime values of arrhyth mic ratio (Fig. 4) . Nicainoprol at the doses of 1 to 3 mg/kg were examined in the pre liminary experiments.
Nicainoprol at a dose of 1 mg/kg showed only a weak antiarrhyth mic effect; therefore, the dose of 3 mg/kg was chosen for this study. The arrhythmic ratio decreased from 3 to 40 min after injec tion. The plasma nicainoprol concentration time curves for each experiment fitted well with that predicted by the two-compartment open model. The parameters of the curves were: A=29.36±6.17 /cg/ml, alpha=0.636± 0.205/min, B=4.52+2.09 /cg/ml, and beta= 0.012±0.002/min (n=6). The calculated minimum antiarrhythmic plasma concen tration of nicainoprol for canine digitalis induced arrhythmia (at 40 min) was 3.0+1.3 dig/ml. Effects of nicainoprol on adrenaline induced arrhythmia: Adrenaline infusion at rates of 2.5-3.5 ~.tg/kg/min induced ven tricular tachycardia of nearly 250 beats/min and consisted almost entirely of ventricular ectopic beats. Nicainoprol at the doses of 1-3 mg/kg were examined in the preliminary study. Nicainoprol at the lowest dose of 1 mg/ kg had only a transient antiarrhythmic effect; therefore, a dose of 3 mg/kg was used. As shown in Fig. 5 , ventricular ectopic beats disappeared after injection of nicainoprol, and the arrhythmic ratio decreased to 0 and then gradually started to increase after 3 min after the injection. However, the statistically significant decrease lasted up to the last min of infusion of adrenaline, 1 5 min. The plasma concentration-time curves of the short 15 min observation period fitted well that predicted by the one-compartment, open model theory. Fig. 4 . Summary of the effects of nicainoprol, 3 mg/kg, i.v., on digitalis-induced arrhythmia . Nicainoprol decreased the total heart rate and arrhythmic ratio and increased the number of conducted beats . *P<0.05.
The parameters of the curves, which cor responded roughly to the distribution phase of the aforementioned two compartment model curves, were: A=38.4±33.3 ucg/ml and alpha=0.381 ±0.2-43/min (n=6).
The an tiarrhythmic nicainoprol plasma concentra tions for canine adrenaline-induced arrhyth mia at 15 min was 2.7+0.8 /tg/ml. Relationship between nicainoprol plasma concentration and its antiarrhythmic effect: .All the plasma concentration data and the corresponding values of the arrhythmic ratio obtained were plotted as in Fig. 6 . Among the 5 straight lines, those of the coronary ligation arrhythmia experiments showed statistically significant correlations (P-0.01), but the negative correlation coefficients (r) were not as high (0.43-0.50).
The two straight line relationships obtained from intravenous and oral administration experiments of 24 hr coronary ligation arrhythmia were almost identical. Nicainoprol showed a long lasting antiarrhythmic effect up to the end of adrenaline infusion. **P<0.01. Discussion The present experiment using three canine ventricular arrhythmia models confirmed pre vious reports (2) that nicainoprol is effective in animal experimental arrhythmias. Our ex periment using 5 mg/kg, i.v. and 30-40 mg/ kg, p.o. of nicainoprol showed that it had an tiarrhythmic effect on the coronary ligation arrhythmias, but simultaneously had central nervous excitatory effects including vomiting. The minimum effective concentrations could only be determined for 48 hr coronary ligation arrhythmia and was 8.9 /cg/ml. However, as shown in the concentration-effect relation ships of Fig. 6 , nicainoprol had a concen tration-dependent antiarrhythmic effect on 24 hr coronary ligation arrhythmia (Fig. 6 ), but much higher concentrations must be required to decrease the arrhythmic ratio than that of the 48 hr coronary ligation experi ments. This may indicate that 24 hr coronary ligation arrhythmia is more severe as com pared to 48 hr arrhythmia.
The antiarrhythmic plasma concentration for digitalis arrhythmia was 3.0 ag/ml, signifi cantly lower than those obtained in the coronary ligation arrhythmias.
The in vivo threshold concentration of nicainoprol to induce Na channel depression was reported to be about 10-5 M (1 ), i.e., 3.7 /cg/ml, so as we have already hypothesized (4), the an tiarrhythmic mechanism of nicainoprol for digitalis and coronary ligation arrhythmias must be due to Na channel depression.
Our minimum effective plasma concen tration data of nicainoprol shows that nicaino prol suppressed adrenaline induced arrhyth mia also at a concentration less than 2.7 ,ag/ ml. Since nicainoprol has been shown to have weak beta blocking action, it is reasonable that this antiarrhythmic effect might be due to indirect Ca channel inhibition, through sup pression of beta receptors, which is an im portant mechanism for suppression of the adrenaline arrhythmia (6).
Comparing the present results with our previous data on various antiarrhythmic drugs using the three ventricular arrhythmia models (Table 1) , the pattern of effectiveness of nica inoprol is comparable to that of aprindine in that they have equipotent effects on digitalis and adrenaline arrhythmias, while they have a weaker effect on coronary ligation arrhythmia . As for the relatively weak antiarrhythmic ac tivity on coronary ligation arrhythmia, pro pafenone is also similar to nicainoprol. Pro pafenone is a class 1 Na channel blocking antiarrhythmic drug with beta blocking ac tivity (5). Though the results of animal ex periments do not necessarily mean effec tiveness in patients, the results of the present experiments showing a wide range of ef fectiveness in dogs make us expect that nicainoprol may become a therapeutically effective drug.
The correlation of the plasma concentration of nicainoprol and its antiarrhythmic effect was examined as in our previous papers (10-13), and it was again shown that there is a statistically significant correlation, but the negative correlation coefficients are not high. Thus the present study suggests again that the absolute values of the plasma concentration of an antiarrhythmic drug are less helpful in predicting the antiarrhythmic effects, while sequential determination of drug plasma con centration is useful in predicting changes in the antiarrhythmic effect and detecting the toxicity of drugs (13).
Since antiarrhythmic effects of nicaino prol were shown in animal models, and this drug has no serious cardiovascular and central nervous system side effects, if orally adminis tered at proper dosage, it may be worth determining clinically whether nicainoprol can become a useful drug for ventricular arrhythmias.
